Corline Biomedical AB

ACTIVE

Swedenwww.corline.comPublic1–10 employeesEstablished: 1991-01-01

Clinical Trials

3 active

Approvals

Total approvals

Agencies

Regulatory bodies

Founded

1991

Overview

Trial Phase Distribution

Phase

Trials

Phase 1

50.0%

Phase 2

33.3%

Not Applicable

16.7%

Trial Status Distribution

Active, not recruiting

33.3%

Completed

16.7%

Not yet recruiting

16.7%

Unknown

16.7%

Withdrawn

16.7%

Clinical Trials

Trials sponsored by this organization (6)

A 3-month, phase 2, single-blind, randomised, no-treatment controlled study assessing efficacy and safety of Renaparin® for improvement of kidney graft function in deceased-donor transplant recipients, with an additional 9-month follow-up.

Phase 1

Active, not recruiting

Jun 202380 participants

A 3-month, phase 2, single-blind, randomised, no-treatment controlled study assessing efficacy and safety of Renaparin® for improvement of kidney graft function in deceased-donor transplant recipients, with an additional 9-month follow-up.

Phase 1

Active, not recruiting

Sep 202280 participants

Renaparin® in Kidney Transplantation

Phase 1

Completed

interventional

Feb 201916 participants

Heparinized Islets in Clinical Islet Transplantation

Not Applicable

Unknown

interventional

Jan 201910 participants

A 3-month, phase 2, single-blind, randomised, no-treatment controlled study assessing efficacy and safety of Renaparin® for improvement of kidney graft function in deceased-donor transplant recipients, with an additional 9-month follow-up.

Phase 2

Not yet recruiting

52 participants

A 3-month, phase 2, single-blind, randomised, no-treatment controlled study assessing efficacy and safety of Renaparin® for improvement of kidney graft function in deceased-donor transplant recipients, with an additional 9-month follow-up.

Phase 2

Withdrawn

45 participants

Approvals

No approval data available

News

No news articles found

Back to Organizations